These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Neoadjuvant concurrent chemotherapy and radiotherapy in non-small cell lung cancer. Ramella S; Ciresa M; Massaccesi M; Franceschini G; D'Angelillo RM; Trodella L Rays; 2004; 29(4):439-43. PubMed ID: 15852733 [TBL] [Abstract][Full Text] [Related]
24. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer. Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402 [TBL] [Abstract][Full Text] [Related]
25. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group. Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975 [TBL] [Abstract][Full Text] [Related]
26. Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer. Vokes EE; Crawford J; Bogart J; Socinski MA; Clamon G; Green MR Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5045s-5050s. PubMed ID: 16000612 [TBL] [Abstract][Full Text] [Related]
27. Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer. Takigawa N; Kiura K; Segawa Y; Watanabe Y; Kamei H; Moritaka T; Shibayama T; Ueoka H; Gemba K; Yonei T; Tabata M; Shinkai T; Hiraki S; Takemoto M; Kanazawa S; Matsuo K; Tanimoto M; Br J Cancer; 2006 Nov; 95(9):1142-4. PubMed ID: 17031394 [TBL] [Abstract][Full Text] [Related]
28. Strategies for enhanced radiation delivery in patients with lung cancer. Mañon R; Mehta M Expert Opin Drug Deliv; 2005 Jan; 2(1):103-13. PubMed ID: 16296738 [TBL] [Abstract][Full Text] [Related]
29. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial. Pallarés C; Capdevila J; Paredes A; Farré N; Ciria JP; Membrive I; Basterrechea L; Gomez-Segura G; Barnadas A Lung Cancer; 2007 Nov; 58(2):238-45. PubMed ID: 17658655 [TBL] [Abstract][Full Text] [Related]
30. Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. Sarna L; Swann S; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Byhardt R; Wasserman T; Movsas B Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1378-84. PubMed ID: 18501528 [TBL] [Abstract][Full Text] [Related]
31. Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer. Thatcher N; Faivre-Finn C; Blackhall F; Anderson H; Lorigan P Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5051s-5056s. PubMed ID: 16000613 [TBL] [Abstract][Full Text] [Related]
32. [Combined modality treatment of chemotherapy and radiotherapy for unresectable non-small cell lung cancer]. Kubota K Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():384-9. PubMed ID: 9369912 [TBL] [Abstract][Full Text] [Related]
33. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer. Ajlouni M; Chapman R; Kim JH Cancer J Sci Am; 1996; 2(6):314-20. PubMed ID: 9166551 [TBL] [Abstract][Full Text] [Related]
34. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?]. Baumann M Strahlenther Onkol; 2001 Apr; 177(4):220-1. PubMed ID: 11370558 [No Abstract] [Full Text] [Related]
35. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer. Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281 [No Abstract] [Full Text] [Related]
36. Non-small cell lung cancer, nonsurgical, aggressive therapy. American College of Radiology. ACR Appropriateness Criteria. Komaki R; Sause WT; Byhardt RW; Curran WJ; Fuller D; Graham MV; Ko B; Weisenburger TH; Kaiser LR; Leibel SA; Choi NC Radiology; 2000 Jun; 215 Suppl():1319-30. PubMed ID: 11037549 [No Abstract] [Full Text] [Related]
37. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer. Belani CP; Wang W; Johnson DH; Wagner H; Schiller J; Veeder M; Mehta M; J Clin Oncol; 2005 Jun; 23(16):3760-7. PubMed ID: 15837967 [TBL] [Abstract][Full Text] [Related]
38. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature? Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975 [TBL] [Abstract][Full Text] [Related]